Apex-IHN® which is the trademark for the vaccine is protecting against a very severe disease hitting salmon farming in British Columbia, Canada. Pan Fish has carried out extensive testing of the vaccine and documented its safety and efficacy.
The approval of the vaccine is an important milestone in preventing IHN and in general to increase the biological security in the fish farming business in Canada. To Pan Fish Canada and other farmers this provides higher stability and basis for profitable fish farming in a region located close to one of the world's most attractive salmon markets; the US west coast market.
For further information, please contact:
Cato Lyngøy, VP Technology/Biosecurity +47 930 11 330
Recommended Reading
-
With reference to stock exchange notice of 13 May 2026 and partly remuneration to Mowi ASA’s shareholder-elected Board members in the form of shares. Board members of Mowi have today purchased shares...
Read More -
The shares in Mowi ASA will be traded ex-dividend of NOK 2.30 as from today 28 August 2026. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian...
Read More